Dupilumab reduces mucus plugging and improves lung function in patients with moderate-to-severe type 2 asthma.

In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among ...

Most patients with chronic rhinosinusitis with nasal polyps no longer used oral corticosteroids after using dupilumab, ...

Please provide your email address to receive an email when new articles are posted on . The Asthma Impairment and Risk Questionnaire (AIRQ) measures current control and future exacerbation risk. 35% ...

Mepolizumab significantly reduces exacerbations in patients with asthma and concurrent chronic obstructive pulmonary disease (COPD), with a 55% reduction in COPD exacerbations post initiation. A ...

Patients with asthma who were with or without a diagnosis of nasal polyps were found to have results with long-term dupilumab. A study published in Annals of Allergy, Asthma & Immunology found that ...

Asian woman using a pressurized cartridge inhaler extended pharynx, Bronchodilator The observational study that enrolled 2847 adult patients with severe asthma receiving maintenance systemic ...

Spontaneous pneumomediastinum (SPM) refers to the presence of free air in the mediastinum without preceding trauma or ...

Nektar Therapeutics (NASDAQ:NKTR) shares climbed 3.6% on Monday after the biotech firm unveiled encouraging new data showing ...

About 30 to 40% of children with asthma experience sleep difficulties due to symptoms like coughing and wheezing. Poor sleep ...

For the primary endpoint, Eczema Area and Severity Index (EASI) improved by 53-61% in a dose-dependent manner across the ...